-
公开(公告)号:NO20013409A
公开(公告)日:2001-08-30
申请号:NO20013409
申请日:2001-07-10
Applicant: BASF AG
Inventor: STEINLER GERD , SCHELLHAAS KURT , LUBISCH WILFRIED , HOLZENKAMP UTA , STARCK DOROTHEA , KNOPP MONIKA , SZABO LASZLO , EMLING FRANZ , GARCIA-LADONA FRANCISCO-JAVIER , HOFMANN HANS PETER , UNGER LILIANE
IPC: C07D495/04 , A61K31/505 , A61K31/519 , A61P9/10 , C07D495/14
CPC classification number: A61K31/505
-
公开(公告)号:BG104873A
公开(公告)日:2001-07-31
申请号:BG10487300
申请日:2000-10-17
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG , KNOPP MONIKA
IPC: C07D295/08 , A61K31/16 , A61K31/166 , A61K31/27 , A61K31/395 , A61K31/40 , A61K31/455 , A61K31/495 , A61K31/535 , A61K31/5375 , A61P9/00 , A61P13/12 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P27/12 , A61P29/00 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07C229/38 , C07C237/20 , C07C237/22 , C07C237/32 , C07C237/36 , C07D209/14 , C07D213/82 , C07D233/64 , C07D237/32 , C07D237/36 , C07D295/14 , C07D295/155
Abstract: The invention relates to cysteine protease inhibitors of the general formula in which A is -(CH2)p-R1, where R1 can be pyrrolidine, morpholine, piperidine, -NR5R6 and formula and p can be 1 or 2; B can be possibly phenyl, pyridyl, pyrimidyl and pyridazyl; D is a bond, -(CH2)m-, CH=CH, -C¾C-; R2 is chlorine, bromine, fluorine, alkyl, NHCO alkyl, NHCO2 alkyl, NO2, -O-alkyl and NH2; R3 is an alkyl which can carry a possibly substituted phenyl ring, indolyl ring and cyclohexyl ring; and Y is phenyl, pyridine, pyrimidine and pyrazine; R4 is hydrogen, COOR9 and CO-Z, where Z is NR10R11 and formulae n is O, 1 or 2 and m is 0, 1, 2, 3 or 4. 19 claims
-
公开(公告)号:HRP20000777A2
公开(公告)日:2001-06-30
申请号:HRP20000777
申请日:2000-11-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG , KNOPP MONIKA
IPC: C07D295/08 , A61K31/18 , A61K31/27 , A61K31/4409 , A61K31/4418 , A61P9/00 , A61P13/12 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P29/00 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07C233/78 , C07C235/42 , C07C237/34 , C07C311/21 , C07D213/56 , C07D295/096 , A61K31/44
Abstract: Benzamides of the formula Iand its tautomeric forms, possible enantiomeric and diastereomeric forms, E and Z forms, and possible physiologically tolerated salts, in which the variables have the following meanings:R1-C1-C6-alkyl, branched or unbranched, where one of the C atoms in this chain may be substituted by a phenyl ring, cyclohexyl ring, indolyl ring and an SCH3 group, and the phenyl ring in turn is substituted by by [sic] a maximum of two R4 radicals, where R4 [lacuna] hydrogen, C1-C4-alkyl, branched or unbranched, -O-C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, NHCO-C1-C4-alkyl, andR2 can be NR5CO-R6 and NHR5SO2-R6, andR3 is chlorine, bromine, fluorine, C1-C6-alkyl, NHCO-C1-C4-alkyl, NHSO2-C1-C4-alkyl, NO2, -O-C1-C4-alkyl, CN, COOH, CONH2, COO-C1-C4-alkyl, SO2-C1-C4-alkyl, -SO2Ph, SO2NH-C1-C4-alkyl, iodine, SO2NH2 and NH2, andA can be aromatic rings and heteroaromatic rings such as naphthyl, quinolyl, quinoxyl, benzimidazolyl, benzothienyl, quinazolyl, phenyl, thienyl, imidazolyl, pyridyl, pyrimidyl and pyridazyl, it also being possible for the rings to be substituted by by [sic] R9 and up to 2 R8 radicals, andB a bond, -(CH2)m-, -(CH2)m-O-(CH2)o-, -(CH2)o-S-(CH2)m-, -(CH2)o-SO-(CH2)m-, -(CH2)o-SO2-(CH2)m-, -CH=CH-, -C=C-, -CO-CH=CH-, -(CH2)o-CO-(CH2)m-, -(CH2)m-NHCO-(CH2)o-, -(CH2)m-CONH-(CH2)o-, -(CH2)m-NHSO2-(CH2)o-, -NH-CO-CH=CH-, -(CH2)m-SO2NH-(CH2)o-,A-B together alsoR5 hydrogen and C1-C4-alkyl andR6 is hydrogen, phenyl, naphthyl, C1-C6-alkyl, linear or branched, it being possible for a C atom in the chain to be substituted by a phenyl ring which itself may also be substituted by one or two R4 radicals, andR8 can be hydrogen, C1-C4-alkyl, branched or unbranched, -O-C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, -NHCO-C1-C4-alkyl, phenyl, NHCO-phenyl, -NHSO2-C1-C4-alkyl, -NHSO2-phenyl, -SO2-C1-C4-alkyl, pyridine [sic] and SO2-phenyl,R9 hydrogen, -CHR14-(CH2)p-R12 where R12 pyrrolidine [sic], morpholine [sic], piperidine [sic], hexahydroazepine [sic], homopiperazine [sic], and R10 [lacuna] C1-C6-alkyl, branched or unbranched, and which may also carry a phenyl ring which is in turn substituted by by [sic] a maximum of two R11 radicals, where R11 is hydrogen, C1-C4-alkyl, branched or unbranched, -O-C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, NHCO-C1-C4-alkyl, -NHSO2-C1-C4-alkyl and -SO2-C1-C4-alkyl; andR13 is hydrogen and C1-C6-alkyl, branched or unbranched, andn,p is [sic], independently of one another, a number 0, 1 or 2, andm,o is [sic], independently of one another, a number 0, 1, 2, 3 or 4.
-
公开(公告)号:HRP20000776A2
公开(公告)日:2001-06-30
申请号:HRP20000776
申请日:2000-11-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG , KNOPP MONIKA
IPC: A61K31/196 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/47 , A61K31/517 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P27/12 , A61P43/00 , C07C233/76 , C07C237/22 , C07C311/21 , C07D213/56 , C07D215/36 , C07D239/70 , C07D239/96 , C07C237/52 , C07C235/82 , A61K31/195 , A61K31/44 , A61K31/505 , A61K31/19
Abstract: Amides of the general formula Iand their tautomeric and isomeric forms, possible enantiomeric and diastereomeric forms, as well as possible physiologically tolerable salts, in which the variables have the following meanings:R1 [sic] can be C1-C6-alkyl, phenyl, naphthyl, quinolyl, pyridyl, pyrimidyl, pyridazyl, quinazolyl and quinoxalyl, where the rings can additionally be substituted by up to 2 radicals R4 [sic], andR2 [sic] is -(CH2)m-R8 [sic], where R8 [sic] can be phenyl, cyclohexyl- or indolyl and m=1 to 6, andX is a bond, -CH2-, -CH2CH2-, -CH=CH-, -C=C-, -CONH-, -SO2NH- [sic], and and [sic]R1-X [sic] together are also andR3 [sic] is hydrogen and CO-NR6R7 [sic],R4 [sic] is hydrogen, C1-C4-alkyl [sic], which is branched and unbranched, and -O-C1-C4-alkyl [sic];R5 [sic] is hydrogen, C1-C4-alkyl [sic], which is branched or unbranched, and -O-C1-C4-alkyl [sic];R6 [sic] is hydrogen, C1-C6-alkyl, which is branched and unbranched, andR7 [sic] is hydrogen, C1-C6-alkyl, which is branched or unbranched, andn is is [sic] a number 0, 1 or 2.
-
公开(公告)号:BG104885A
公开(公告)日:2001-05-31
申请号:BG10488500
申请日:2000-10-24
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOELLER ACHIM , TREIBER HANS-JOERG , KNOPP MONIKA
IPC: C07D295/14 , A61K31/18 , A61K31/357 , A61K31/36 , A61K31/40 , A61K31/437 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/445 , A61K31/4453 , A61K31/453 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/495 , A61K31/496 , A61K31/5375 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P29/00 , A61P35/00 , A61P35/04 , A61P43/00 , C07C237/32 , C07C311/08 , C07C311/21 , C07D207/06 , C07D207/36 , C07D211/14 , C07D213/30 , C07D213/36 , C07D213/40 , C07D213/48 , C07D213/56 , C07D213/71 , C07D213/76 , C07D215/06 , C07D215/36 , C07D215/40 , C07D217/04 , C07D239/28 , C07D295/13 , C07D295/155 , C07D317/54 , C07D317/58 , C07D401/12 , C07D403/04 , C07D498/04 , C07D295/12 , A61K31/50 , C07D215/24 , C07D213/70
Abstract: The invention relates to amides of the general formula which are inhibitors of enzymes, especially cysteine proteases 23 claims
-
公开(公告)号:SK13942000A3
公开(公告)日:2001-05-10
申请号:SK13942000
申请日:1999-04-19
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG , KNOPP MONIKA
IPC: A61K31/196 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/47 , A61K31/517 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P27/12 , A61P43/00 , C07C233/76 , C07C237/22 , C07C311/21 , C07D213/56 , C07D215/36 , C07D239/70 , C07D239/96 , C07C237/52 , C07C235/82 , A61K31/195 , A61K31/44 , A61K31/505 , A61K31/19
Abstract: Amides of the general formula Iand their tautomeric and isomeric forms, possible enantiomeric and diastereomeric forms, as well as possible physiologically tolerable salts, in which the variables have the following meanings:R1 [sic] can be C1-C6-alkyl, phenyl, naphthyl, quinolyl, pyridyl, pyrimidyl, pyridazyl, quinazolyl and quinoxalyl, where the rings can additionally be substituted by up to 2 radicals R4 [sic], andR2 [sic] is -(CH2)m-R8 [sic], where R8 [sic] can be phenyl, cyclohexyl- or indolyl and m=1 to 6, andX is a bond, -CH2-, -CH2CH2-, -CH=CH-, -C=C-, -CONH-, -SO2NH- [sic], and and [sic]R1-X [sic] together are also andR3 [sic] is hydrogen and CO-NR6R7 [sic],R4 [sic] is hydrogen, C1-C4-alkyl [sic], which is branched and unbranched, and -O-C1-C4-alkyl [sic];R5 [sic] is hydrogen, C1-C4-alkyl [sic], which is branched or unbranched, and -O-C1-C4-alkyl [sic];R6 [sic] is hydrogen, C1-C6-alkyl, which is branched and unbranched, andR7 [sic] is hydrogen, C1-C6-alkyl, which is branched or unbranched, andn is is [sic] a number 0, 1 or 2.
-
公开(公告)号:SK13932000A3
公开(公告)日:2001-05-10
申请号:SK13932000
申请日:1999-04-20
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG , KNOPP MONIKA
IPC: C07D295/12 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4545 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/551 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P43/00 , C07D213/80 , C07D213/81 , C07D213/82 , C07D215/50 , C07D239/42 , C07D295/192 , C07D401/04 , C07D401/14 , C07D405/12 , C07D413/12 , C07D317/60 , C07D295/155 , A61K31/495 , A61K31/505 , A61K31/455
Abstract: Heterocyclically substituted amides of the general formula Iwherein the variables as defined in the specification are useful in pharmaceuticals for the treatment of diseases in which increased interleuken-1 levels occur.
-
公开(公告)号:CZ20003868A3
公开(公告)日:2001-03-14
申请号:CZ20003868
申请日:1999-04-19
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MUELLER ACHIM , TREIBER HANS-JOERG , KNOPP MONIKA
IPC: A61K31/50 , C07C237/32 , C07C311/08 , C07C311/21 , C07D207/06 , C07D213/30 , C07D213/70 , C07D215/06 , C07D215/24 , C07D217/04 , C07D295/12 , C07D317/58 , C07D403/04
-
公开(公告)号:ID26980A
公开(公告)日:2001-02-22
申请号:ID20002135
申请日:1999-04-19
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG , KNOPP MONIKA
IPC: A61K31/4164 , A61K31/426 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/505 , A61K31/506 , A61K31/5377 , A61P9/04 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/28 , A61P27/12 , A61P43/00 , C07D213/81 , C07D213/82 , C07D233/90 , C07D239/28 , C07D239/30 , C07D239/42 , C07D241/28 , C07D277/20 , C07D277/44 , C07D277/56 , C07D401/04 , C07D401/12 , C07D413/12 , A61K31/44
Abstract: Amides of the general formula Iand their tautomeric and isomeric forms, possible enantiomeric and diastereomeric forms, as well as possible physiologically tolerable salts, in which the variables have the meanings stated in the description, their preparation and use as calpain inhibitors.
-
公开(公告)号:BR9909773A
公开(公告)日:2000-12-19
申请号:BR9909773
申请日:1999-04-20
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MULLER ACHIM , TREIBER HANS-JURG , KNOPP MONIKA
IPC: C07D295/12 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4545 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/551 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P43/00 , C07D213/80 , C07D213/81 , C07D213/82 , C07D215/50 , C07D239/42 , C07D295/192 , C07D401/04 , C07D401/14 , C07D405/12 , C07D413/12 , C07D317/60 , C07D295/155 , A61K31/495 , A61K31/505 , A61K31/455 , A61K31/44
Abstract: Heterocyclically substituted amides of the general formula Iwherein the variables as defined in the specification are useful in pharmaceuticals for the treatment of diseases in which increased interleuken-1 levels occur.
-
-
-
-
-
-
-
-
-